We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

133 hedge funds and large institutions have $1.19B invested in Translate Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 46 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

656% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 9

318% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 11

127% more capital invested

Capital invested by funds: $525M → $1.19B (+$666M)

80% more funds holding

Funds holding: 74 → 133 (+59)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

27% more call options, than puts

Call options by funds: $6.25M | Put options by funds: $4.94M

Holders
133
Holders Change
+59
Holders Change %
+79.73%
% of All Funds
2.73%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
68
Increased
46
Reduced
11
Closed
9
Calls
$6.25M
Puts
$4.94M
Net Calls
+$1.31M
Net Calls Change
+$1.11M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$26.9M
2
BlackRock
BlackRock
New York
+$22.4M
3
State Street
State Street
Massachusetts
+$18.1M
4
Millennium Management
Millennium Management
New York
+$17.6M
5
KSCM
Key Square Capital Management
Connecticut
+$15.2M

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$24.3M
2
CCM
Camber Capital Management
Massachusetts
-$11.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.42M
4
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
-$2.7M
5
RSCM
Rock Springs Capital Management
Maryland
-$2.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$5.14M +$3.51M +232,984 +431%
JP Morgan Chase
27
JP Morgan Chase
New York
$4.77M +$2.24M +148,452 +126%
MIM
28
Monashee Investment Management
Massachusetts
$4.48M +$3.77M +250,000 New
BCPEMI
29
Bain Capital Public Equity Management II
Massachusetts
$4.26M -$2.7M -179,167 -43%
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
$4.17M +$3.51M +232,549 New
LCM
31
Laurion Capital Management
New York
$4.15M +$3.49M +231,400 New
N
32
Nuveen
North Carolina
$3.87M +$1.17M +77,288 +56%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$3.83M +$1.08M +71,467 +50%
LP
34
LMR Partners
United Kingdom
$3.56M +$3M +198,700 New
MAM
35
Martingale Asset Management
Massachusetts
$3.38M +$2.84M +188,613 New
Allianz Asset Management
36
Allianz Asset Management
Germany
$2.33M +$1.96M +129,708 New
Charles Schwab
37
Charles Schwab
California
$2.3M +$554K +36,733 +40%
PCM
38
Pinz Capital Management
New York
$2.25M +$1.9M +125,800 New
EI
39
EAM Investors
California
$2.23M +$1.88M +124,550 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.86M +$740K +49,081 +89%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.81M +$1.3M +85,965 +573%
HI
42
HBK Investments
Texas
$1.79M +$1.51M +100,000 New
Bessemer Group
43
Bessemer Group
New Jersey
$1.72M +$1.45M +96,200 New
Arrowstreet Capital
44
Arrowstreet Capital
Massachusetts
$1.7M +$1.43M +94,678 New
Wells Fargo
45
Wells Fargo
California
$1.69M +$1.1M +72,999 +340%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.65M +$780K +51,700 +129%
CCM
47
Copernicus Capital Management
California
$1.61M +$1.36M +90,000 New
EGI
48
EAM Global Investors
California
$1.61M +$1.36M +89,937 New
PM
49
Prosight Management
Texas
$1.6M +$1.35M +89,510 New
TI
50
Trexquant Investment
Connecticut
$1.47M +$1.23M +81,887 New
1
2
3 4 5

TBIO Hedge Fund Activity: Q2 2020 in Review

133 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q2 2020, worth a combined $1.19B — up 127% from $525M a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new TBIO positions and 9 closed out — a net gain of 59 holders — while 46 added to existing stakes and 11 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $26.9M. The largest seller was Omega Fund Management, exiting entirely with an estimated $24.3M sold.

  • 133 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q2 2020, up from 74 in Q1 2020.
  • Funds reported $1.19B of Translate Bio, Inc. Common Stock stock for Q2 2020, up 127% quarter-over-quarter.
  • 68 funds opened new Translate Bio, Inc. Common Stock positions in Q2 2020 and 9 closed out, a net change of +59 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q2 2020 was T. Rowe Price Associates, an estimated $26.9M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q2 2020 was Omega Fund Management, an estimated $24.3M sold.

Based on aggregated 13F filings for Q2 2020.